Protecting Canadians from Excessive Drug Prices: Consulting on Proposed Amendments to the Patented Medicines Regulations – May 2017

  • Knowledge Library
  • Resources
  • Reports
  • Protecting Canadians from Excessive Drug Prices: Consulting on Proposed Amendments to the Patented Medicines Regulations - May 2017

A report from Health Canada, providing ways to reduce the cost of patented drugs. All through the modernization of a pricing framework under the Patented Medicine Prices Review Board (PMRPB).

Download the full report here

Previous Pharmacare 2020: The Future of Drug Coverage in Canada
Next Reformulary Group: ReModel Sample Report – May 2017